TEST BANK FOR Advanced Practice Nursing
m m m m m
m in the Care of Older Adults, 2nd Edition
m m m m m m m m
by Laurie Kennedy-Malone, Verified Chapters 1 - 19, Complete
m m m m m m m m
,
,Answers at the end of the Chapter
m m m m m m m
Chapter 1: Changes with Aging
m m m m
Multiple mChoice
Identify mthe mchoice mthat mbest mcompletes mthe mstatement mor manswers mthe mquestion.
1. The mmajor mimpact mof mthe mphysiological mchanges mthat moccur mwith maging mis:
A. Reduced mphysiological mreserve
B. Reduced mhomeostatic mmechanisms
C. Impaired mimmunological mresponse
D. All mof mthe mabove
2. The mstrongest mevidence mregarding mnormal mphysiological maging mis mavailable mthrough:
, A. Randomized mcontrolled mclinical mtrials
B. Cross-sectional mstudies
C. Longitudinal mstudies
D. Case mcontrol mstudies
mm m 3. m All mof mthe mfollowing mstatements mare mtrue mabout mlaboratory
values min molder madultsexcept:
A. Reference mranges mare mpreferable
B. Abnormal mfindings mare moften mdue mto mphysiological maging
C. Normal mranges mmay mnot mbe mapplicable mfor molder madults
D. Reference mvalues mare mnot mnecessarily macceptable mvalues
mm m 4. m Biochemical mindividuality mis mbest mdescribed mas:
A. Each mindividual’s mvariation mis moften mmuch mgreater mthan mthat mof ma mlarger mgroup
B. The munique mbiochemical mprofile mof ma mselected mpopulation
C. The mtruly m“normal” mindividual—falling mwithin maverage mrange
D. Each mindividual’s mvariation mis moften mmuch msmaller mthan mthat mof ma mlarger mgroup
mm m 5. m Polypharmacy mis mbest mdescribed mas mtaking:
A. More mthan mnine mmedications mper mday
B. More mthan mfive mmedications mper mday
m m m m m
m in the Care of Older Adults, 2nd Edition
m m m m m m m m
by Laurie Kennedy-Malone, Verified Chapters 1 - 19, Complete
m m m m m m m m
,
,Answers at the end of the Chapter
m m m m m m m
Chapter 1: Changes with Aging
m m m m
Multiple mChoice
Identify mthe mchoice mthat mbest mcompletes mthe mstatement mor manswers mthe mquestion.
1. The mmajor mimpact mof mthe mphysiological mchanges mthat moccur mwith maging mis:
A. Reduced mphysiological mreserve
B. Reduced mhomeostatic mmechanisms
C. Impaired mimmunological mresponse
D. All mof mthe mabove
2. The mstrongest mevidence mregarding mnormal mphysiological maging mis mavailable mthrough:
, A. Randomized mcontrolled mclinical mtrials
B. Cross-sectional mstudies
C. Longitudinal mstudies
D. Case mcontrol mstudies
mm m 3. m All mof mthe mfollowing mstatements mare mtrue mabout mlaboratory
values min molder madultsexcept:
A. Reference mranges mare mpreferable
B. Abnormal mfindings mare moften mdue mto mphysiological maging
C. Normal mranges mmay mnot mbe mapplicable mfor molder madults
D. Reference mvalues mare mnot mnecessarily macceptable mvalues
mm m 4. m Biochemical mindividuality mis mbest mdescribed mas:
A. Each mindividual’s mvariation mis moften mmuch mgreater mthan mthat mof ma mlarger mgroup
B. The munique mbiochemical mprofile mof ma mselected mpopulation
C. The mtruly m“normal” mindividual—falling mwithin maverage mrange
D. Each mindividual’s mvariation mis moften mmuch msmaller mthan mthat mof ma mlarger mgroup
mm m 5. m Polypharmacy mis mbest mdescribed mas mtaking:
A. More mthan mnine mmedications mper mday
B. More mthan mfive mmedications mper mday
